These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38458656)

  • 21. [Not Available].
    Heppner HJ
    Drug Res (Stuttg); 2019 Nov; 69(S 01):S21-S22. PubMed ID: 31731307
    [No Abstract]   [Full Text] [Related]  

  • 22. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2019.
    Am J Health Syst Pharm; 2019 Jun; 76(13):e8-e9. PubMed ID: 31361888
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.
    Mendes D; Rigueiro G; Silva RS; Penedones A; Alves C; Sousa G; Batel-Marques F
    J Oncol Pharm Pract; 2020 Jan; 26(1):133-140. PubMed ID: 31117914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public-academic partnerships: a program to improve the quality of antipsychotic prescribing in a community mental health system.
    Brunette MF; de Nesnera A; Swain K; Riera EG; Lotz D; Bartels SJ
    Psychiatr Serv; 2011 Sep; 62(9):1004-6. PubMed ID: 21885576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing Medicines for Use in the Geriatric Population.
    Cerreta F; Vučić K; Laslop A
    Clin Pharmacol Ther; 2023 Mar; 113(3):536-540. PubMed ID: 36354419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety update: methotrexate and photosensitivity reactions.
    Drug Ther Bull; 2023 Nov; 61(12):179. PubMed ID: 37845001
    [No Abstract]   [Full Text] [Related]  

  • 27. MHRA issues two updates on fluoroquinolone safety.
    Drug Ther Bull; 2024 Jan; 62(2):19. PubMed ID: 38123946
    [No Abstract]   [Full Text] [Related]  

  • 28. Understanding the implementation and adoption of a technological intervention to improve medication safety in primary care: a realist evaluation.
    Jeffries M; Phipps DL; Howard RL; Avery AJ; Rodgers S; Ashcroft DM
    BMC Health Serv Res; 2017 Mar; 17(1):196. PubMed ID: 28288634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier.
    Alves C; Marques FB; Macedo AF
    Eur J Clin Pharmacol; 2014 Jun; 70(6):745-56. PubMed ID: 24691786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug related problems in Belgian community pharmacies].
    Huysmans K; De Wulf I; Foulon V; De Loof H; Steurbaut S; Boussery K; De Vriese C; Lacour V; Van Hees T; De Meyer GR
    J Pharm Belg; 2014 Mar; (1):4-15. PubMed ID: 24804389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
    Holbrook AM
    Ann Intern Med; 2023 Jun; 176(6):JC70. PubMed ID: 37276599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporating the Beers criteria may reduce ED visits in elderly persons.
    Razzi CC
    J Emerg Nurs; 2009 Sep; 35(5):453-4. PubMed ID: 19748030
    [No Abstract]   [Full Text] [Related]  

  • 33. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):e375-7. PubMed ID: 27208062
    [No Abstract]   [Full Text] [Related]  

  • 34. Safer medicines management in primary care.
    Avery AJ; Sheikh A; Hurwitz B; Smeaton L; Chen YF; Howard R; Cantrill J; Royal S
    Br J Gen Pract; 2002 Oct; 52 Suppl(Suppl):S17-22. PubMed ID: 12389765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward safer prescribing: evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea.
    Kim SJ; Han KT; Kang HG; Park EC
    Public Health; 2018 Oct; 163():128-136. PubMed ID: 30145461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States.
    Mintzes B; Lexchin J; Sutherland JM; Beaulieu MD; Wilkes MS; Durrieu G; Reynolds E
    J Gen Intern Med; 2013 Oct; 28(10):1368-75. PubMed ID: 23558775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspects of the safety of medicines.
    Harris EL
    Rheumatol Phys Med; 1972 Nov; 11(8):431-5. PubMed ID: 4646492
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on metformin safety in pregnancy.
    Drug Ther Bull; 2022 Jul; 60(7):99. PubMed ID: 35768138
    [No Abstract]   [Full Text] [Related]  

  • 39. The challenge of prescribing drugs in older people.
    Lattanzio F; Corsonello A
    Curr Drug Metab; 2011 Sep; 12(7):599-600. PubMed ID: 22196227
    [No Abstract]   [Full Text] [Related]  

  • 40. Fifty years of pharmacovigilance - Medicines safety and public health.
    Laporte JR
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.